177 related articles for article (PubMed ID: 10075590)
21. The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients.
Kotb M; Russell WC; Hathaway DK; Gaber LW; Gaber AO
Clin Transplant; 1999 Feb; 13(1 Pt 2):83-9. PubMed ID: 10081642
[TBL] [Abstract][Full Text] [Related]
22. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
[TBL] [Abstract][Full Text] [Related]
23. Value of a flow cytometry cross-match in the setting of a negative complement-dependent cytotoxicity cross-match in heart transplant recipients.
Keeshan BC; O'Connor MJ; Lin KY; Monos D; Lind C; Mascio CE; Rame JE; Spray TL; Shaddy RE; Rossano JW
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28766759
[TBL] [Abstract][Full Text] [Related]
24. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch.
Lazda VA
Transplantation; 1994 Mar; 57(6):964-9. PubMed ID: 8154047
[TBL] [Abstract][Full Text] [Related]
25. Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions.
Putheti P; Liwski RS; Jindra PT
Hum Immunol; 2022 May; 83(5):467-475. PubMed ID: 35183390
[TBL] [Abstract][Full Text] [Related]
26. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection.
Ferry BL; Welsh KI; Dunn MJ; Law D; Proctor J; Chapel H; Yacoub MH; Rose ML
Transpl Immunol; 1997 Mar; 5(1):17-24. PubMed ID: 9106330
[TBL] [Abstract][Full Text] [Related]
27. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
[TBL] [Abstract][Full Text] [Related]
28. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
[TBL] [Abstract][Full Text] [Related]
29. Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation.
Contreras AG; Casillas-Abundis A; Alberú J; Llorente L; Lima G; Arvizu A; de Santiago A; Vilatobá M; Granados J; Morales-Buenrostro LE; Cruz R; Arreola-Guerra JM
Transpl Immunol; 2018 Oct; 50():8-14. PubMed ID: 29885443
[TBL] [Abstract][Full Text] [Related]
30. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
[TBL] [Abstract][Full Text] [Related]
31. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
33. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
34. Effect of IgM-positive crossmatches on survival in heart transplant recipients.
Scheinin SA; Radovancević B; Kimball P; Duncan JM; Van Buren CT; Frazier OH; Kerman R
Tex Heart Inst J; 1995; 22(1):67-71. PubMed ID: 7787472
[TBL] [Abstract][Full Text] [Related]
35. Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.
Everly MJ; Rebellato LM; Haisch CE; Briley KP; Bolin P; Kendrick WT; Kendrick SA; Morgan C; Maldonado AQ; Harland RC; Terasaki PI
Transplantation; 2014 Mar; 97(5):494-501. PubMed ID: 24487396
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.
Takakura K; Kiuchi T; Kasahara M; Uryuhara K; Uemoto S; Inomata Y; Tanaka K
Clin Transplant; 2001 Oct; 15(5):309-16. PubMed ID: 11678956
[TBL] [Abstract][Full Text] [Related]
37. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of flow cytometry crossmatching in heart transplantation.
Bishay ES; Cook DJ; Starling RC; Ratliff NB; White J; Blackstone EH; Smedira NG; McCarthy PM
Eur J Cardiothorac Surg; 2000 Apr; 17(4):362-9. PubMed ID: 10773556
[TBL] [Abstract][Full Text] [Related]
39. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
40. A retrospective flow cytometric crossmatch study in transplant recipients with autoreactive lymphocytotoxic antibodies.
Martin S; Davies MS; Robson AJ
Transpl Int; 1994; 7 Suppl 1():S527-31. PubMed ID: 11271299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
